TCF Ep. 521 - Stephen Wilkes

Published: July 6, 2020, 8:27 p.m.

b'Since opening his studio in New York City in 1983, photographer Stephen Wilkes has built an unprecedented body of work and a reputation as one of America\\u2019s most iconic photographers, widely recognized for his fine art, editorial and commercial work. Wilkes\\u2019 early career interpretations of Mainland China, California\\u2019s Highway One, and impressionistic \\u201cBurned Objects\\u201d set the tone for a series of career-defining projects that catapulted him to the top of the photographic landscape. Day to Night, Wilkes\\u2019 most defining project, began in 2009. These epic cityscapes and landscapes, portrayed from a fixed camera angle for up to 30 hours capture fleeting moments of humanity as light passes in front of his lens over the course of a full day. Blending these images into a single photograph takes months to complete. Day to Night has been featured on CBS Sunday Morning as well as dozens of other prominent media outlets and, with a grant from the National Geographic Society, was recently extended to include America\\u2019s National Parks in celebration of their centennial anniversary and Bird Migration for the 2018 Year of the Bird. Day to Night: In the Field with Stephen Wilkes was exhibited at The National Geographic Museum in February 2018. \\xa0 Photographer Links:\\xa0 Stephen Wilkes Jay Myself Film Jay Maisel Girault de Prangey \\xa0 Education Resources: Creating Personal Breakthroughs Tokyo: Exploration of the Metropolis 2.0 Momenta Photographic Workshops https://momentaworkshops.com/workshops/ \\xa0 Candid Frame Resources Making Photographs: Developing a Personal Visual Workflow Download the free Candid Frame app for your favorite smart device. Click here to download for . Click here to download Support the work we do at The Candid Frame with contributing to our Patreon effort.\\xa0 You can do this by visiting or visiting the website and clicking on the Patreon button. You can also provide a one-time donation via . You can follow Ibarionex on and .'